Showing results (1621-1630 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|July 13, 2026
Endovascular Treatment for Acute Ischemic Stroke: A Methodological Systematic Review of Health Economic Decision Modeling StudiesAndreas Beisel, Hans-Helmut König, Judith Dams
Pharmacoeconomics|March 23, 2026
Economic Evaluation of Pre-emptive Pharmacogenetic Panel Testing versus No Genetic Testing in a Multi-ethnic Asian PopulationJamaica Roanne Briones, Jia Hui Chai, Yaroslava Zemlyanska, et al.
Pharmacoeconomics|April 1, 2026
Utilization and Lifetime Costs of Formal Care for Alzheimer's Disease Dementia in SwedenXin Xia, Maria Eriksdotter, Alice Clark, et al.
Pharmacoeconomics|September 4, 2026
Landscape Analysis of Literature Using Quantitative Approaches to Synthesize Economic Evaluation Studies: A Scoping ReviewSajesh K Veettil, Christy Thomas, Chan Jia En, et al.
Pharmacoeconomics|July 17, 2026
Comparing User-Written Codes for Performing Economic Evaluations in StataBradley Barker-Jones, Patricia Navvuga, Petra Baji, et al.
Pharmacoeconomics|September 22, 2026
Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 YearsCamilla Nystrand, Naimi Johansson, Johannes Blom
Pharmacoeconomics|September 17, 2026
Beyond Narrative and Tabular Synthesis: Introducing an Approach-Rationale-Note (ARN) Framework for Thematic Evidence Synthesis in Economic Evaluation ReviewsMehdi Yousefi, Amy Grove, Jo Parsons, et al.
Pharmacoeconomics|October 6, 2026
Methods in Systematic Reviews of Health Economic Evaluations in Submissions to Health Technology Assessment Agencies: How Systematic Are They, and Does This Matter?Chris Bartlett, Rachael McCool, Matthew Taylor
Pharmacoeconomics|September 30, 2026
Meta-Analysis of Incremental Net Benefit from Trial-Based Health Economic Evaluations in R: A TutorialRomain Jonathan Collet, Johanna Maria van Dongen, Oraluck Pattanaprateep, et al.
Pharmacoeconomics|October 9, 2026
Methodological Challenges and Preferred Approaches for the Economic Evaluation of CAR T Therapies: Evidence Review and Expert Consensus from NICE AppraisalsMehdi Yousefi, Amin Mehrabian, Maeve A O'Reilly, et al.
Pageof 336